Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
Sadaf Aslam
1
,
Adriana van de Guchte
1
,
Zenab Khan
1
,
Ajay Obla
1
,
Jayeeta Dutta
1
,
H van Bakel
1
,
Judith A. Aberg
1
,
Rafael Medina
1
,
G. L. Shah
2
,
Tobias M. Hohl
2
,
Genovefa A. Papanicolaou
2
,
Kent Sepkowitz
2
,
Esther Babady
2
,
Mini Kamboj
2
Publication type: Journal Article
Publication date: 2020-12-01
scimago Q1
wos Q1
SJR: 19.076
CiteScore: 96.4
Impact factor: 78.5
ISSN: 00284793, 15334406
PubMed ID:
33259154
General Medicine
Abstract
Shedding of SARS-CoV-2 after Immunosuppression The prolonged contagious period after viral infection in immunocompromised patients may affect how long precautions will be necessary to reduce furthe...
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
2
4
6
8
10
12
|
|
|
Clinical Infectious Diseases
12 publications, 3.17%
|
|
|
Open Forum Infectious Diseases
12 publications, 3.17%
|
|
|
medRxiv : the preprint server for health sciences
9 publications, 2.37%
|
|
|
Journal of Infectious Diseases
8 publications, 2.11%
|
|
|
Viruses
7 publications, 1.85%
|
|
|
Journal of Infection and Chemotherapy
7 publications, 1.85%
|
|
|
Transplantation and Cellular Therapy
6 publications, 1.58%
|
|
|
Transplant Infectious Disease
6 publications, 1.58%
|
|
|
British Journal of Haematology
5 publications, 1.32%
|
|
|
Frontiers in Immunology
5 publications, 1.32%
|
|
|
Frontiers in Medicine
5 publications, 1.32%
|
|
|
BMC Infectious Diseases
5 publications, 1.32%
|
|
|
Journal of Medical Virology
5 publications, 1.32%
|
|
|
Infectious Diseases
5 publications, 1.32%
|
|
|
International Journal of Molecular Sciences
4 publications, 1.06%
|
|
|
Nature Communications
4 publications, 1.06%
|
|
|
Journal of Infection
4 publications, 1.06%
|
|
|
Clinical Microbiology and Infection
4 publications, 1.06%
|
|
|
Infection Control and Hospital Epidemiology
4 publications, 1.06%
|
|
|
bioRxiv
4 publications, 1.06%
|
|
|
Frontiers in Oncology
3 publications, 0.79%
|
|
|
Leukemia
3 publications, 0.79%
|
|
|
American Journal of Transplantation
3 publications, 0.79%
|
|
|
International Journal of Infectious Diseases
3 publications, 0.79%
|
|
|
Clinics in Laboratory Medicine
3 publications, 0.79%
|
|
|
Transplantation Proceedings
3 publications, 0.79%
|
|
|
The Lancet Microbe
3 publications, 0.79%
|
|
|
European Journal of Cancer
3 publications, 0.79%
|
|
|
BMJ Case Reports
3 publications, 0.79%
|
|
|
2
4
6
8
10
12
|
Publishers
|
10
20
30
40
50
60
70
80
90
|
|
|
Elsevier
86 publications, 22.69%
|
|
|
Springer Nature
51 publications, 13.46%
|
|
|
Wiley
44 publications, 11.61%
|
|
|
Oxford University Press
38 publications, 10.03%
|
|
|
Cold Spring Harbor Laboratory
31 publications, 8.18%
|
|
|
MDPI
26 publications, 6.86%
|
|
|
Frontiers Media S.A.
18 publications, 4.75%
|
|
|
Taylor & Francis
16 publications, 4.22%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
9 publications, 2.37%
|
|
|
BMJ
8 publications, 2.11%
|
|
|
Cambridge University Press
5 publications, 1.32%
|
|
|
American Society for Microbiology
4 publications, 1.06%
|
|
|
SAGE
3 publications, 0.79%
|
|
|
American Association for the Advancement of Science (AAAS)
3 publications, 0.79%
|
|
|
American Society of Hematology
3 publications, 0.79%
|
|
|
S. Karger AG
2 publications, 0.53%
|
|
|
Massachusetts Medical Society
2 publications, 0.53%
|
|
|
American Medical Association (AMA)
2 publications, 0.53%
|
|
|
American Association for Cancer Research (AACR)
2 publications, 0.53%
|
|
|
AME Publishing Company
2 publications, 0.53%
|
|
|
XMLink
2 publications, 0.53%
|
|
|
American Society for Clinical Investigation
1 publication, 0.26%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 0.26%
|
|
|
Spandidos Publications
1 publication, 0.26%
|
|
|
Georg Thieme Verlag KG
1 publication, 0.26%
|
|
|
Japanese Society of Internal Medicine
1 publication, 0.26%
|
|
|
IOP Publishing
1 publication, 0.26%
|
|
|
Public Library of Science (PLoS)
1 publication, 0.26%
|
|
|
Annual Reviews
1 publication, 0.26%
|
|
|
10
20
30
40
50
60
70
80
90
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
379
Total citations:
379
Citations from 2024:
67
(17.68%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Aydillo T. A. et al. Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer // New England Journal of Medicine. 2020. Vol. 383. No. 26. pp. 2586-2588.
GOST all authors (up to 50)
Copy
Aydillo T. A., Gonzalez-Reiche A. S., Aslam S., van de Guchte A., Khan Z., Obla A., Dutta J., van Bakel H., Aberg J. A., Medina R., Shah G. L., Hohl T. M., Papanicolaou G. A., Perales M., Sepkowitz K., Babady E., Kamboj M. Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer // New England Journal of Medicine. 2020. Vol. 383. No. 26. pp. 2586-2588.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1056/NEJMc2031670
UR - https://doi.org/10.1056/NEJMc2031670
TI - Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
T2 - New England Journal of Medicine
AU - Aydillo, Teresa A.
AU - Gonzalez-Reiche, Ana Silvia
AU - Aslam, Sadaf
AU - van de Guchte, Adriana
AU - Khan, Zenab
AU - Obla, Ajay
AU - Dutta, Jayeeta
AU - van Bakel, H
AU - Aberg, Judith A.
AU - Medina, Rafael
AU - Shah, G. L.
AU - Hohl, Tobias M.
AU - Papanicolaou, Genovefa A.
AU - Perales, Miguel-Angel
AU - Sepkowitz, Kent
AU - Babady, Esther
AU - Kamboj, Mini
PY - 2020
DA - 2020/12/01
PB - Massachusetts Medical Society
SP - 2586-2588
IS - 26
VL - 383
PMID - 33259154
SN - 0028-4793
SN - 1533-4406
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2020_Aydillo,
author = {Teresa A. Aydillo and Ana Silvia Gonzalez-Reiche and Sadaf Aslam and Adriana van de Guchte and Zenab Khan and Ajay Obla and Jayeeta Dutta and H van Bakel and Judith A. Aberg and Rafael Medina and G. L. Shah and Tobias M. Hohl and Genovefa A. Papanicolaou and Miguel-Angel Perales and Kent Sepkowitz and Esther Babady and Mini Kamboj},
title = {Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer},
journal = {New England Journal of Medicine},
year = {2020},
volume = {383},
publisher = {Massachusetts Medical Society},
month = {dec},
url = {https://doi.org/10.1056/NEJMc2031670},
number = {26},
pages = {2586--2588},
doi = {10.1056/NEJMc2031670}
}
Cite this
MLA
Copy
Aydillo, Teresa A., et al. “Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer.” New England Journal of Medicine, vol. 383, no. 26, Dec. 2020, pp. 2586-2588. https://doi.org/10.1056/NEJMc2031670.